University of North Carolina, Chapel Hill: HIV Infections trials

The registry lists 87 HIV Infections studies with University of North Carolina, Chapel Hill as lead sponsor. 1 are open to participants now and 27 have results posted.

Phase 1 7Phase 2 6Phase 4 6No phase 68(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Reducing Stigma and Building Employability Skills for Young People With HIV in ZambiaRecruitingNCT07732660Not applicable
• Male Partner Engagement in HIV Testing Using Partner-notification Slip Plus Oral HIV Self-testing KitCompletedNCT07488221Not applicableResults posted
• HIV Engagement and Adolescent Depression Support (HEADS-UP)CompletedNCT06173544Not applicableResults posted
• Impact of a Telenovela/Soap Opera for HIV Prevention in LatinasCompletedNCT05929482Not applicableResults posted
• Package of Resources for Assisted Contact Tracing: Implementation, Costs, and EffectivenessCompletedNCT05343390Not applicableResults posted
• HIV And Parasitic Infection (HAPI) StudyCompletedNCT05323396Not applicableResults posted
• Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant WomenCompletedNCT04900974Phase 1Results posted
• Scaling up an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam: an Implementation TrialCompletedNCT03952520Not applicableResults posted
• Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI TractCompletedNCT03917420Phase 1Results posted
• Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM)CompletedNCT03414372Not applicableResults posted
• Triggered Escalating Real-time Adherence (TERA) InterventionCompletedNCT03292432Not applicableResults posted
• Innovations in HIV Testing (TI)CompletedNCT03271424Not applicableResults posted
• ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-AdherenceCompletedNCT03218592Phase 4Results posted
• Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)CompletedNCT03212989Phase 1Results posted
• AllyQuest: Engaging HIV+ YMSM in Care Through Social Networking and GamificationCompletedNCT03090958Not applicableResults posted
• The Compartmental Biology of HIV in the Male Genital TractCompletedNCT02638493Results posted
• Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV InfectionCompletedNCT02384395Not applicableResults posted
• Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive AdultsCompletedNCT02218320Results posted
• An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure ProphylaxisCompletedNCT01772823Phase 2Results posted
• Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).CompletedNCT01769469Results posted
• An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)CompletedNCT01769456Phase 2Results posted
• Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cARTCompletedNCT01751646Not applicableResults posted
• Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV InfectionCompletedNCT00959894Phase 2Results posted
• Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)CompletedNCT00924898Phase 4Results posted
• HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and EtravirineTerminatedNCT00855413Phase 4Results posted
• Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young WomenCompletedNCT00710593Phase 2Results posted
• MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV InfectionTerminatedNCT00614458Phase 2Results posted
• Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)CompletedNCT00491556Not applicableResults posted
• Food as Medicine for HIV and DiabetesActive, not recruitingNCT05026723Not applicable
• HIV Reengagement and Assessment Mobile Program (Project RAMP)CompletedNCT04151498Not applicable
• Integrating PrEP Into Family Planning Services at Title X Clinics in the Southeastern USCompletedNCT04097834
• Innovations in HIV TestingCompletedNCT03162965Not applicable
• Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPACompletedNCT03153709
• Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral LoadCompletedNCT02720237Not applicable
• Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 InfectionTerminatedNCT02707900Phase 1
• A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in ChinaCompletedNCT02516930Not applicable
• ART Readiness in HIV-infected Pregnant WomenCompletedNCT02459678Not applicable
• Factors Affecting PrEP AdherenceCompletedNCT02411630
• The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in ZambiaCompletedNCT02012816Not applicable
• Feasibility of Using a Structured Daily DiaryCompletedNCT01953653Not applicable
• Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV PreventionCompletedNCT01752504Not applicable
• Efficacy of HIV Post-Test Support for ANC in South AfricaCompletedNCT01683461Not applicable
• Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TXCompletedNCT01629316Not applicable
• Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)CompletedNCT01502618Not applicable
• Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIVCompletedNCT01492842
• Enhancement of Connect to Protect® (C2P)CompletedNCT01492816Not applicable
• Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected AdolescentsWithdrawnNCT01492803Not applicable
• HIV Diagnosis in Hospitalized Malawian InfantsCompletedNCT01388452Not applicable
• HIV and Drug Use in Georgian WomenCompletedNCT01331460Not applicable
• Managerial Database IICompletedNCT01322217
• Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed InfantsCompletedNCT01222130
• Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young AdultsCompletedNCT01203332
• Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected PopulationCompletedNCT01180075
• Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women PrisonersCompletedNCT01111721Not applicable
• Cell Phone Reminders InterventionCompletedNCT01049568Not applicable
• Preventative Misconception InterventionCompletedNCT01049139Not applicable
• Computerized HIV/Sexually Transmitted Disease (STD) Prevention ProgramCompletedNCT00947947Phase 2
• Linkage to Care - Part IICompletedNCT00891644
• Empowerment Intervention for Young Women - Phase ICompletedNCT00891358Not applicable
• Treatment De-Intensification and Residual HIV-1 in YouthCompletedNCT00867854
• Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal TissueCompletedNCT00855088Phase 1
• ID and Testing Via Friendship NetworksCompletedNCT00841360
• Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal TissueCompletedNCT00775294Phase 1
• Community-based Evaluation of a Pilot PMTCT Project in Kafue DistrictCompletedNCT00753428
• Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of ZambiaCompletedNCT00753324Phase 4
• HIV Treatment-Readiness Measure (HTRM) ValidationCompletedNCT00686049
• Neurocognitive Assessment in Youth Initiating HAARTCompletedNCT00683579
• Vitamin D Reabsorption in Adolescents and Young Adults With HIV InfectionCompletedNCT00490412Not applicable
• Microbicides Acceptability Among Sexually Active Young WomenCompletedNCT00490152
• Engaging Care for HIV-infected Adolescent Females.CompletedNCT00489034
• C2P Mobilization Intervention (Pilot)CompletedNCT00393575Not applicable
• C2P - Phase III: MPowerment and Community PromiseCompletedNCT00381784Not applicable
• Study of Valproic Acid to Treat HIV Infected AdultsTerminatedNCT00312546Phase 1
• PK of Once Daily ART Containing Tenofovir and Atazanavir/RitonavirCompletedNCT00273273
• Life Skills Intervention for Adolescents Perinatally Infected With HIVCompletedNCT00272519Not applicable
• C2P (With Venues): Connect to Protect® Partnerships For Youth Prevention InterventionsCompletedNCT00271908
• Metabolic Abnormalities - HIV Infected and Uninfected MalesCompletedNCT00260936
• Family-based HIV Prevention for Adolescent GirlsCompletedNCT00243126Not applicable
• Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their CaregiversTerminatedNCT00224900
• Immunologic Memory (Supp. of ATN 024)CompletedNCT00142753Phase 4
• Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ YouthCompletedNCT00107029
• Typology of Adherence in Adolescents: Phase IICompletedNCT00106678
• Connect to Protect Partnerships for Youth Prevention Interventions: Phase IICompletedNCT00103896
• A Novel Method to Determine HIV Incidence Among YouthCompletedNCT00103883
• Healthy Choices to Promote Health and Reduce Risk in HIV-Infected YouthCompletedNCT00103532Not applicable
• 4-Day-A-Week Treatment Plan for HIV Infected AdolescentsCompletedNCT00068809Phase 4
• Treatment Plan to Decrease Drug Exposure in HIV Infected AdolescentsWithdrawnNCT00067574Not applicable